SLC6A14 and malignant colon neoplasm: With this small molecule, published reports have demonstrated the therapeutic utility of SLC6A14 blockade in the treatment of multiple tumor types that are associated with upregulation of this transporter: breast cancer [72,73,74], pancreatic cancer [76,95], and colon cancer [69].